Quanterix Corporation Common Stock (QTRX) is a publicly traded Healthcare sector company. As of November 9, 2026, QTRX trades at $2.92 with a market cap of $136.91M and a P/E ratio of -1.39. QTRX moved +0.00% today. Year to date, QTRX is -54.98%; over the trailing twelve months it is -41.98%. Its 52-week range spans $2.15 to $8.77. Analyst consensus is neutral with an average price target of $3.25. Rallies surfaces QTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks QTRX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $2.92 |
| Market Cap | $136.91M |
| P/E Ratio | -1.39 |
| EPS | $-2.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.77 |
| 52-Week Low | $2.15 |
| Volume | 20.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $153.41M |
| Net Income | $-123.11M |
| Gross Margin | 42.69% |
2 analysts cover QTRX: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.25.